View Press Releases
-
Gifthealth is First to Serve 6m Patients Via Direct-to-Patient Platform
Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.
Oct 6, 2025
-
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows
-
CluePoints’ AI Breakthroughs Earn Dual Recognition at SCDM and SCRIP Awards
CluePoints, provider of leading statistical and AI-driven software solutions, has achieved dual recognition, winning the Clinical Data Science Implementation Excellence Award at the 2025 SCDM Annual Conference and has been named a finalist in the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 SCRIP Awards.
Oct 6, 2025
-
Association for Molecular Pathology Develops Standardized Biomarker Report Template for Providers
AMP announced the publication of a new simplified, consensus-driven NGS molecular biomarker report designed to support oncologists and other healthcare providers. This report provides clear, practical recommendations to help laboratories present complex molecular profiling data in a format that is both clinically useful and consistent with current guidelines.
Oct 7, 2025
-
Lonza Expands its TheraPEAK® Product Portfolio with the Addition of AmpliCell® Cytokine Range and TheraPEAK® 293-GT® Medium
Lonza has announced the launch of TheraPEAK® AmpliCell® Cytokines and TheraPEAK® 293-GT® Medium to expand its GMP solutions for cell and gene therapy.
Oct 5, 2025
-
Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards
Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.
Oct 5, 2025
-
Symeres appoints Gabriella Gentile as Chief Operating Officer to drive transatlantic growth
-
STEM, Inizio Advisory Launches STEM AI to Deliver Intelligent, Data-Led HCP Interactions
-
XenoSTART and Minerva Imaging Expand Partnership to Deliver Integrated PDX-Radiopharmaceutical Drug Development Platform
Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development.
Oct 1, 2025
-
Transforming Drug Target Discovery, Insilico Medicine Publishes Landmark Paper Introducing AI-empowered Target Identification Pro (TargetPro) and TargetBench 1.0
- Insilico published a new study unveiling Target Identification Pro (TargetPro), a superior disease-specific model, and TargetBench 1.0, the first standardized benchmarking framework for target discovery. - TargetPro achieved 71.6% retrieval of known clinical targets, a 2–3x improvement over large language models (LLMs) such as GPT-4o, Grok3, DeepSeek-R1, Claude-Opus-4, BioGPT, and public platforms like Open Targets. - TargetPro’s predicted novel targets demonstrated 95.7% structure availability, 86.5% druggability, and 46% repurposing potential, outperforming competing systems on all measures. - TargetBench’s explainable AI models revealed disease-specific feature importance patterns, emphasizing the value of disease-specific target identification models. - New gold standard approaches improve accuracy, reliability, and transparency in AI-driven drug discovery.
Oct 2, 2025
-
Advarra’s site-sponsor consortium publishes industry report and master mutual CDA template to streamline feasibility and reduce study startup timelines
Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the Site-Sponsor Consortium’s first industry deliverable designed to streamline a common bottleneck in clinical trials: the Confidential Disclosure Agreement (CDA).
Sep 30, 2025
-
KROHNE Introduces OPTIWAVE 1530 & 1560 Radar Level Transmitters
-
Quantabio Advances Newborn Screening and Emerging Applications by Streamlining DNA Extraction from Dried Blood Spot Samples
Quantabio has launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.
Sep 29, 2025
-
Ambience Healthcare Becomes First Ambient AI Platform to Launch Inpatient CDI at the Point of Care, Built on OpenAI
-
OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform
-
Oklahoma’s Largest Locally Owned Health Plan Selects 1upHealth as a Strategic Interoperability Partner
-
Clearwater Receives Strategic Growth Investment from Sunstone Partners
-
ZeOmega Named Leader in Everest Group’s PEAK® Matrix Assessment for Second Consecutive Year
-
Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification
-
P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software
Pathologists readily embrace the shift to digital workflows.
Sep 29, 2025